Literature DB >> 29085791

Bronchial Wash Gene Xpert MTB/RIF in Lower Lung Field Tuberculosis: Sensitive, Superior, and Rapid in Comparison with Conventional Diagnostic Techniques.

Shital Patil1, Swati Narwade2, Mazhar Mirza3.   

Abstract

BACKGROUND: Lower lung field tuberculosis (LLF TB) is an atypical presentation of tuberculosis (TB). LLF TB is common, and a proportionate number of non-resolving pneumonia cases are diagnosed to have pulmonary TB.
MATERIALS AND METHODS: The prospective observational study was conducted during June 2013 to December 2015 in the Department of Pulmonary Medicine, MIMSR Medical College, Latur, India; the objective of the study is clinical, microbiological, and radiological presentation of LLF TB and the comparison of yield of conventional diagnostic techniques and bronchoscopy-guided modalities in LLF TB. Additional important objective of the study is to find LLF TB in patients with nonresolving pneumonia (NRP). A total of 2,600 patients with pulmonary TB were included in the study after inclusion and exclusion criteria. Ethical clearance was taken from the ethical committee of the institutional review board. Consent was taken from the patients before inclusion in the study. Statistical analysis was done using chi-square test.
RESULTS: In the present study, 300 (11.53%) cases of LLF TB of total 2600 pulmonary tuberculosis were included, females constitutes 66.66% (200/300) with mean age of 58.4 ± 11.8 years and males constitutes 33.34% (100/300) with mean age of 56.8 ± 10.6 years. Constitutional symptoms were observed as cough in 93% cases, fever in 83% cases, shortness of breath in 72% cases, anorexia in 91% cases, and weight loss in 84% cases. Radiological assessment of study cases documented the involvement of right lower zone in 84% cases and left lower zone in only 16% cases. In the studied LLF TB cases, 57 cases (20.66%) were diagnosed by routine sputum microscopic examination for acid fast bacilli (AFB) and 80 cases (28%) were diagnosed by induced sputum microscopic examination for AFB. In the study of 170 LLF TB cases, head-to-head comparison between conventional diagnostic techniques (sputum microscopy and Induced sputum microscopy for AFB) made diagnosis in 60 cases, while bronchoscopy-guided sampling techniques (BAL for AFB and BAL for Gene Xpert MTB/RIF) made diagnosis in 155 cases (91.17%) (P < 0.00001). Comorbid conditions such as human immunodeficiency virus (HIV) coinfection in 36 cases (12.00%), Diabetes mellitus in 64 cases (21.33%), and chronic kidney disease (CKD) in 22 cases (7.33%) were observed. Comorbidities were observed in 41.67% of the studied cases and found very significant assessment to have successful treatment outcome (P < 0.00001). In the study of 300 LLF TB cases, 60 cases were having NRP pattern. In LLF TB cases with NRP pattern, bronchoscopy-guided bronchial wash microscopy for AFB made diagnosis in 18 cases (42%), while bronchoscopy-guided BAL for Gene Xpert MTB/RIF made diagnosis in 58 cases (96.66%) (P < 0.00001).
CONCLUSION: LLF TB is usually underdiagnosed because of diverse clinical and radiological presentation, less diagnostic yield of conventional diagnostic modalities, and these modalities used routinely and universally. Bronchoscopy-guided diagnostic techniques are superior, sensitive, and reliable to confirm LLF TB. Gene Xpert MTB/RIF in bronchial wash samples is found to be best diagnostic modality in evaluating LLF TB and should be used routinely to have successful treatment outcome. A proportionate number of NRP cases are having LLF TB and a high index of suspicion is a must while evaluating these cases.

Entities:  

Keywords:  BAL Gene Xpert MTB/RIF; bronchoscopy; lower lung field tuberculosis (LLF TB); treatment outcome

Year:  2017        PMID: 29085791      PMCID: PMC5655465          DOI: 10.1515/jtim-2017-0030

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


  23 in total

1.  Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.

Authors:  Arzu N Zeka; Sezai Tasbakan; Cengiz Cavusoglu
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

3.  Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

Authors:  Sylvie Armand; Pascale Vanhuls; Guy Delcroix; René Courcol; Nadine Lemaître
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis.

Authors:  H Y Lee; M W Seong; S S Park; S-S Hwang; J Lee; Y S Park; C H Lee; S-M Lee; C-G Yoo; Y W Kim; S K Han; J-J Yim
Journal:  Int J Tuberc Lung Dis       Date:  2013-04-23       Impact factor: 2.373

Review 5.  Lower lung field tuberculosis.

Authors:  H W Berger; M G Granada
Journal:  Chest       Date:  1974-05       Impact factor: 9.410

Review 6.  Slowly resolving, chronic, and recurrent pneumonia.

Authors:  S H Kirtland; R H Winterbauer
Journal:  Clin Chest Med       Date:  1991-06       Impact factor: 2.878

7.  Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).

Authors:  S D Greenberg; D Frager; B Suster; S Walker; C Stavropoulos; A Rothpearl
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

8.  Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis.

Authors:  Pierre Le Palud; Vincent Cattoir; Brigitte Malbruny; Romain Magnier; Karine Campbell; Youssef Oulkhouir; Gérard Zalcman; Emmanuel Bergot
Journal:  BMC Pulm Med       Date:  2014-08-12       Impact factor: 3.317

9.  A study on non-resolving pneumonia with special reference to role of fiberoptic bronchoscopy.

Authors:  Arunabha D Chaudhuri; Subhasis Mukherjee; Saumen Nandi; Sourin Bhuniya; Sumit R Tapadar; Mita Saha
Journal:  Lung India       Date:  2013-01

10.  Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis.

Authors:  Surendra K Sharma; Mikashmi Kohli; Raj Narayan Yadav; Jigyasa Chaubey; Dinkar Bhasin; Vishnubhatla Sreenivas; Rohini Sharma; Binit K Singh
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

View more
  2 in total

1.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

2.  Role of Bronchial Washing Gene Xpert in Sputum-Scarce Cases of Suspected Pulmonary Tuberculosis.

Authors:  Faisal Faiyaz Zuberi; Sagheer Hussain; Sidra Hameed; Bader Faiyaz Zuberi
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.